KACEY BARB: Open Payments
NPI 1093418014 · CUMBERLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$97 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $143 · 2025 $97
Food & beverage: $97
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Baxter Healthcare | 1 | $14 |
Products named: Ozempic, JARDIANCE, GVOKE HYPOPEN, Hillrom - Vest System Model 105 Home Care.
Industry payments across MD — which companies pay providers there.
